Autism Spectrum Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have a confirmed diagnosis of Autism Spectrum Disorder (ASD) based on standard diagnostic guidelines (DSM-5).
- You are between 3 and 50 years old (inclusive).
- Your ASD has been assessed as any severity level (mild, moderate, or severe) according to standard diagnostic guidelines.
- A parent or legal guardian has given written permission for your participation (required for those who cannot consent for themselves).
- You are physically able and willing to attend and take part in the treatment sessions.
- You are in a stable enough state of physical and mental health to take part in the study.
Who may not be able to join:
- You have a serious medical condition that could make the treatment device unsafe to use, such as severe neurological disorders or epilepsy that is difficult to control (for example, having more than one major seizure per month in the past 3 months, or a history of very long seizures, repeated seizures requiring emergency medication more than once a month, seizures lasting over 10 minutes, or certain severe seizure episodes in the past 9 months — confirm details with trial site).
- You are currently receiving other therapies or treatments specifically for autism at the same time as this trial.
- You are unable to attend treatment sessions regularly due to practical or personal circumstances.
- You have had significant bad reactions to similar treatments or to anesthesia in the past.
- You have serious behavioral problems or a tendency toward aggression that could put yourself or staff members at risk during treatment sessions.
- You have had a significant bacterial, fungal, viral, or other infection in the past 14 days.
- You have a metal implant in your body, a pacemaker, severe claustrophobia (fear of enclosed spaces), or any other condition that would prevent you from safely entering or staying inside the treatment device.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: J R Trujillo, jrtrujillo@neurocytonix.com
Phone: +528135414706
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in Autism Diagnostic Observation Schedule-Second Edition scale scores; Changes in Adaptive Behavioral Assessment System scores; Changes in Childhood Autism Rating Scale scores; Changes in Gilliam Autism Measurement Scale score; Withdrawal Rate; Adherence to Treatment; Treatment Security; Change in the number of seizures or epileptic seizures during the study period; Neurophysiological changes: in functional activity and brain anatomy using Magnetic Resonance Imaging; Neurophysiological changes: in functional activity and brain anatomy using Diffusion Tensor Imaging; Neurophysiological...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.